Crescendo: Angle PLC, Crescendo Biologics Ink Clinical Services Contract
Crescendo to use ANGLE's recently launched Portrait Flex Assay in prostate cancer study.
Read full article »
Crescendo is an England-based clinical-stage immuno-oncology company that researches and develops T-cell human body therapeutics for the treatment of cancer.
Read more